International Journal of Diabetes in Developing Countries is a peer-reviewed journal with a global reach and championed and edited by experts in the field. The journal focuses on the complete spectrum of contemporary clinical and basic sciences as applied to the clinical context, new and emerging technologies, cutting-edge innovations, and future trends in the field of diabetes. The articles are submitted under various categories/classifications like prevalence, epidemiology,  etiopathogenesis, genetic and molecular biology, clinical and psychosocial aspects, complications, emergencies, treatment, management, pharmacoeconomics, quality of life, technology, and community medicine.  It publishes work done in the developing world, especially from countries affected by the epidemic of diabetes, mainly India, Bangladesh, Pakistan, West Africa, Iran, Turkey. The journal also receives submissions from  Japan, Brazil, Nepal, Sri Lanka, and China.
The journal publishes original articles, review articles (only systematic reviews and meta-analysis), editorials, letters to the editor, short articles, case reports, , consensus/guidelines, and position statements.


The journal carefully selects reviewers not only from the developing world but from around the globe based on their substantial years of experience as academicians/clinicians and citable publications to their credit.
Some of the significant reviewer selection tools employed by the journal include author suggested reviewers, classified national and international reviewers registered in the system based on their domain area expertise, Springer Nature reviewer finder tool, similar title Google search,  PubMed search, referenced authors of the specific manuscripts, and other relevant online sources. The EIC also ranks/grades each reviewer at the end of the review process based on the depth and relevance of the review comments submitted, archived and recorded for future reference.
An exhaustive peer review process is stringently followed. New submissions are assessed and prioritized by the editor-in-chief based on a host of factors primarily the relevance with respect to the aim and scope of the journal, and novelty of the science presented. Other assessment criteria include duplicate submission checks, plagiarism indices, submission of standard checklists like CARE guidelines for case reports and PRISMA checklist for review articles, ethical and compliance statements and English language appropriateness,
Manuscripts are assigned to a team of associate editors for initial evaluation for a week to opine on the suitability of the article for the journal. Based on the overall opinion, articles may be immediately rejected at the initial stage by the EIC or rejected after one week of initial evaluation by the editors. Those warranting review are assigned to associate editors who act as handling editors to oversee the review process before submitting their recommendation to the EIC for final approval.
We follow double-blind peer review process that mandates review by at least two/three subject experts. Manuscripts which mandate a statistical evaluation are sent to the biostatisticians who are the statistical editors.
The reviewers may choose to reject after peer-review at the initial stage or advise revisions. The revised version undergoes further rereviews till the article meets the requisite standards of acceptance or rejection.
Final decision is immediately communicated to the author. Turnaround time for acceptance usually ranges from 4-6 months.
Accepted manuscripts undergo rigorous proof reading and copyediting protocols including reference checks and styling conforming to Vancouver style as well as declarations on compliance with ethical requirements, conflict of interest, funding.

To visit our ethics statements please visit the following links:

Conflict of Interest and Ethical Standards:

Informed Consent: SGWID=0-111-6-608209-0

Statement of Human and Animal Rights:

Data transparency

All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards.





Journal information

  • S V Madhu
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

1.013 (2021)
Impact factor
0.939 (2021)
Five year impact factor
49 days
Submission to first decision (Median)
77,780 (2021)

Latest articles

This journal has 25 open access articles

Societies, partners and affiliations

About this journal

Electronic ISSN
Print ISSN
Co-Publisher information

RSSDI Secretariat

Dr Sanjay Agarwal’s Aegle Clinic for Diabetes Care

A-11, Narsimha Housing Society,

194, Boat Club Road,

Pune- 411001 ( India )

Tel : 020-2616003, 8237730003, 9823133669

Email :

Website :

Abstracted and indexed in
  1. Baidu
  2. CAB Abstracts
  4. CNKI
  6. Chemical Abstracts Service (CAS)
  7. Dimensions
  8. EBSCO Academic Search
  10. EBSCO Discovery Service
  11. EBSCO STM Source
  12. EMBASE
  13. EMCare
  14. Google Scholar
  15. IFIS Publishing
  16. Japanese Science and Technology Agency (JST)
  17. Journal Citation Reports/Science Edition
  18. Naver
  19. OCLC WorldCat Discovery Service
  20. Portico
  21. ProQuest-ExLibris Primo
  22. ProQuest-ExLibris Summon
  23. SCImago
  24. SCOPUS
  25. Science Citation Index Expanded (SCIE)
  26. Semantic Scholar
  27. TD Net Discovery Service
  28. UGC-CARE List (India)
  29. Wanfang
Copyright information

Rights and permissions

Springer policies

© Research Society for Study of Diabetes in India